Sharon L. Ripp

机构：Pfizer (United States) · ORCID：0009-0003-1056-8716

发表论文 36 篇 · 总被引 1804 次 · h-index 24

代表论文

Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure–Activity Relationships and Discovery Strategies To Mitigate Drug–Drug Interaction Risks (2012 · Journal of Medicinal Chemistry · 被引 220)
In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective (2009 · Drug Metabolism and Disposition · 被引 161)
Use of Immortalized Human Hepatocytes to Predict the Magnitude of Clinical Drug-Drug Interactions Caused by CYP3A4 Induction (2006 · Drug Metabolism and Disposition · 被引 118)
Deuterium Isotope Effects on Drug Pharmacokinetics. I. System-Dependent Effects of Specific Deuteration with Aldehyde Oxidase Cleared Drugs (2011 · Drug Metabolism and Disposition · 被引 115)
TRANSCRIPTIONAL SUPPRESSION OF CYTOCHROME P450 GENES BY ENDOGENOUS AND EXOGENOUS CHEMICALS (2004 · Drug Metabolism and Disposition · 被引 97)
Evaluation of models for predicting drug–drug interactions due to induction (2010 · Expert Opinion on Drug Metabolism & Toxicology · 被引 83)